Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Recruiting · NCT05137665 · Registry updated 2025-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, movement disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not stated | 2025-11-21 | NCT05137665 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Target ALS Foundation, Inc. | 1 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barrow Neurological Institute | Phoenix | United States | 50 |
| Baylor College of Medicine | Houston | United States | 306 |
| CHALS-CCT UPR MScience | San Juan | Puerto Rico | 1 |
| Columbia University | New York | United States | 154 |
| Georgetown University | Georgetown | United States | 1 |
| Instituto Roosevelt | Bogotá | Colombia | 2 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Mayo Clinic | Jacksonville | United States | 122 |
| Northwestern University | Chicago | United States | 727 |
| University of California San Diego | San Diego | United States | 8 |
| University of Washington | Seattle | United States | 172 |
| Washington University | St Louis | United States | 182 |